WallStreetZenWallStreetZen

NASDAQ: KDNY
CHINOOK THERAPEUTICS INC Stock Ownership - Who owns CHINOOK THERAPEUTICS?

Buy KDNY

Insider buying vs selling

Have CHINOOK THERAPEUTICS INC insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Srinivas AkkarajuDirector2022-05-27570,000$14.00
$7.98MBuy
Eric DobmeierPresident CEO2022-05-255,000$13.03
$65.15kBuy
Andrew James KingChief Scientific Officer2022-04-115,000$0.35
$1.75kBuy
Andrew James KingChief Scientific Officer2022-04-115,000$15.36
$76.81kSell
Andrew James KingChief Scientific Officer2022-02-182,500$13.00
$32.50kSell
Alan GlicklichChief Medical Officer2022-02-112,391$12.74
$30.46kSell
Andrew James KingChief Scientific Officer2022-02-112,498$12.74
$31.83kSell
Eric BjerkholtChief Financial Officer2022-02-11895$12.74
$11.40kSell
Tom FrohlichChief Operating Officer2022-02-113,735$12.74
$47.59kSell
Andrew James KingChief Scientific Officer2022-02-102,500$0.35
$875.00Buy

1 of 5

KDNY insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

KDNY Shareholders

What type of owners hold CHINOOK THERAPEUTICS INC stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Srinivas Akkaraju17.68%9,753,776$182.01MInsider
Morningside Venture Vi Investments Ltd16.86%9,305,532$173.64MInsider
John E. And Lois A. Rogers11.41%6,296,898$117.50MInsider
Ultimate Keen Ltd10.15%5,602,499$104.54MInsider
Samsara Biocapital LLC8.32%4,591,888$85.68MInstitution
Versant Venture Capital Vii LP6.28%3,465,219$64.66MInsider
Blackrock Inc5.54%3,054,997$57.01MInstitution
Deep Track Capital LP5.44%3,000,000$55.98MInstitution
Frazier Life Sciences Management LP4.92%2,712,041$50.61MInstitution
Baker Bros Advisors LP4.23%2,334,102$43.55MInstitution

1 of 3

KDNY vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
KDNY53.42%46.58%Net SellingNet Buying
IMAB21.78%0.00%
CERS84.18%3.85%Net SellingNet Selling
MNKD26.81%73.19%Net BuyingNet Selling
CDMO92.16%7.84%Net SellingNet Buying

CHINOOK THERAPEUTICS Stock Ownership FAQ

Who owns CHINOOK THERAPEUTICS?

CHINOOK THERAPEUTICS (NASDAQ: KDNY) is owned by 80.03% institutional shareholders, 69.77% CHINOOK THERAPEUTICS insiders, and 0.00% retail investors. Srinivas Akkaraju is the largest individual CHINOOK THERAPEUTICS shareholder, owning 9.75M shares representing 17.68% of the company. Srinivas Akkaraju's CHINOOK THERAPEUTICS shares are currently valued at $176.06M.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.